Who owns the CRISPR BY DESIGN trademark?

The CRISPR BY DESIGN trademark is owned by Scribe Therapeutics Inc..

What is the serial number for CRISPR BY DESIGN?

The USPTO serial number for CRISPR BY DESIGN is 90596751.

What is the registration number for CRISPR BY DESIGN?

CRISPR BY DESIGN is registered under USPTO registration number 0.

CRI

USPTO Trademark Record

ABANDONED

CRISPR BY DESIGN

Q: What class is the CRISPR BY DESIGN trademark registered in?

The CRISPR BY DESIGN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

SN 90596751·Reg 0·Filed Mar 23, 2021

Owner Scribe Therapeutics Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

CRISPR BY DESIGN (Serial No. 90596751), Registration No. 0, is a abandoned US trademark filed on Mar 23, 2021 by Scribe Therapeutics Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

Mark Intelligence

CRISPR BY DESIGN (Reg. #0) is an abandoned US trademark that was filed in 2021 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 23, 2021

SERIAL

90596751

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Scribe Therapeutics Inc.

Entity

Corporation

State

Address

1150 Marina Village Parkway, Alameda, CA, 94501

Country

Attorney

NameJohn Paul Oleksiuk

Law firm

John Paul Oleksiuk COOLEY LLP

Docket

333322.20000

Address

1299 PENNSYLVANIA AVENUE, NW, SUITE 700, WASHINGTON, DC 20004, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 23, 2021

Serial Number90596751

Registration No.0

Registration DateDec 31, 1969

Status DateSep 22, 2025

Published for OppositionJun 21, 2022

Mark TypeStandard characters

Attorney Docket333322.20000

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

43 events

ABANDONMENT - NO USE STATEMENT FILED

Sep 22, 2025

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Sep 22, 2025

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 29, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 5 GRANTED

Jan 28, 2025

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Jan 22, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Jan 22, 2025

SOU EXTENSION 5 FILED

DIVISIONAL PROCESSING COMPLETE

Dec 16, 2024

DIVISIONAL PROCESSING COMPLETE

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 16, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 GRANTED

Dec 16, 2024

SOU EXTENSION 4 GRANTED

CORRECTED NOA E-MAILED

Dec 16, 2024

CORRECTED NOA E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 22, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 18, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 23, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

DIVISIONAL REQUEST RECEIVED

Aug 19, 2024

DIVISIONAL REQUEST RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Aug 19, 2024

TEAS REQUEST TO DIVIDE RECEIVED

SOU EXTENSION 4 FILED

Aug 14, 2024

SOU EXTENSION 4 FILED

SOU TEAS EXTENSION RECEIVED

Aug 14, 2024

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 09, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 08, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Feb 08, 2024

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Feb 08, 2024

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 12, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Aug 10, 2023

SOU EXTENSION 2 GRANTED

SOU EXTENSION 2 FILED

Aug 10, 2023

SOU EXTENSION 2 FILED

SOU TEAS EXTENSION RECEIVED

Aug 10, 2023

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 10, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 08, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Feb 08, 2023

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Feb 08, 2023

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 16, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 21, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 21, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 01, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 19, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 26, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 26, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 26, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Oct 28, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 28, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 28, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 27, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 28, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 26, 2021

NEW APPLICATION ENTERED

CRISPR BY DESIGN

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Scribe Therapeutics Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by John Paul Oleksiuk

Resources

Company